Pharmacologic induction of heme oxygenase 1 reduces acute inflammatory arthritis in mice

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2585-2594

  Benallaoua, Mourad ^a   François, Mathias ^a   Batteux, Frédéric ^b   Thelier, Natacha ^a   Shyy, John Y J ^c   Fitting, Catherine ^d   Tsagris, Lydia ^a   Boczkowski, Jorge ^a   Savouret, Jean François ^a   Corvol, Marie Thérèse ^a   Poiraudeau, Serge ^a   Rannou, François ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GELATINASE B; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; PROSTAGLANDIN E2; PROTOPORPHYRIN; PROTOPORPHYRIN IX COBALT; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTHRITIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; JOINT SWELLING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SYMPTOMATOLOGY; THICKNESS; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITORS; HEME OXYGENASE-1; HINDLIMB; INJECTIONS, INTRAPERITONEAL; JOINTS; LIVER; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, TRANSGENIC; PROTOPORPHYRINS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 34547787584     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22749     Document Type: Article

References (41)

1. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
2. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005;174:5016-23.
3. Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, et al. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by Toll-like receptor signaling. Arthritis Rheum 2003;48:642-50.
4. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003;55:241-69.
5. Wamsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996;39:495-503.
6. Murakami Y, Akahoshi T, Kawai S, Inoue M, Kitasato H. Anti-inflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches. Arthritis Rheum 2002;46:2504-13.
7. Gjertsson I, Hultgren OH, Tarkowski A. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol 2002;130:409-14.
8. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, Fearns C, et al. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am J Pathol 2003;163:2555-63.
9. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005;39:1-25.
10. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-55.
11. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, et al. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci U S A 2005;102:7251-6.
12. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004;110:1296-302.
13. Juan SH, Cheng TH, Lin HC, Chu YL, Lec WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol 2005;69:41-8.
14. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002;8:240-6.
15. 2. J Biol Chem 2003;278:19325-30.
16. Kataoka K, Handa H, Nishizawa M. Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds. J Biol Chem 2001;276:34074-81.
17. Sato H, Yamaguchi M, Shibasaki T, Ishii T, Bannai S. Induction of stress proteins in mouse peritoneal macrophages by the antirheumatic agents gold sodium thiomalate and auranofin. Biochem Pharmacol 1995;49:1453-7.
18. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, et al. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A 2001;98:8798-803.
19. Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, et al. Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther 2001;12:967-79.
20. Laniado-Schwartzman M, Abraham NG, Conners M, Dunn MW, Levere RD, Kappas A. Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol 1997;53:1069-75.
21. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000;106:189-97.
22. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-35.
23. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase deficient cells. Proc Natl Acad Sci U S A 1997;94:10925-30.
24. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, et al. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004;165:1045-53.
25. Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum 2006;54:1132-42.
26. Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, et al. Tumor necrosis factor α acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum 2007;56:464-75.
27. Fernandez P, Guillen MI, Gomar F, Alcaraz MJ. Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes. Biochem Pharmacol 2003;66:2049-52.
28. Devesa I, Ferrandiz ML, Busserolles J, Alcaraz MJ. Effects of heme oxygenase-1 inducers on established rat adjuvant arthritis. Cell Mol Biol (Noisy-le-grand) 2005;51:479-85.
29. Devesa I, Ferrandiz ML, Terencio MC, Joosten LA, van den Berg WB, Alcaraz MJ. Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis. Arthritis Rheum 2005;52:3230-8.
30. Devesa I, Ferrandiz ML, Guillen I, Cerda JM, Alcaraz MJ. Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis. Lab Invest 2005;85:34-44.
31. Korganow A, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451-61.
32. De Bandt M, Ben Mahdi MH, Ollivier V, Grossin M, Dupuis M, Gaudry M, et al. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol 2003;171:4853-9.
33. Francois M, Richette P, Tsagris L, Raymondjean M, Fulchignoni-Lataud MC, Forest C, et al. Peroxisome proliferator-activated receptor-γ down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J Biol Chem 2004;279:28411-8.
34. Taille C, Foresti R, Lanone S, Zedda C, Green C, Aubier M, et al. Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am J Respir Crit Care Med 2001;163:753-61.
35. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
36. Zhang X, Shan P, Jiang D, Noble PW, Abraham NG, Kappas A, et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004;279:10677-84.
37. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-22.
38. Ohmura K, Johnsen A, Ortiz-Lopez A, Desany P, Roy M, Besse W, et al. Variation in IL-1β gene expression is a major determinant of genetic differences in arthritis aggressivity in mice. Proc Natl Acad Sci U S A 2005;102:12489-94.
39. Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 1994;13:1225-33.
40. Grundemar L, Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 1997;18:193-5.
41. Zwerina J, Tzima S, Hayer S, Redlich K, Hoffmann O, Hanslik-Schnabel B, et al. Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. FASEB J 2005;19:2011-3.